INDmoney
Ultragenyx Pharmaceutical Inc. Stock Performance
as on January 23, 2026 at 1:39 am IST
Day's Low
Day's High
$22.76$23.87
3.15%
Downside
1.57%
Upside
52 Week's Low
52 Week's High
$18.41$46.5021.66%
Downside
97.87%
Upside
Ultragenyx Pharmaceutical Inc. share price movements today
- Previous Close
- $22.75
- Open
- $22.82
- Volume
- 1.5M
- Day's Low - High
- $22.76 - $23.87
- 52 Week Low - High
- $18.41 - $46.50
Ultragenyx Pharmaceutical Inc. Historical Returns
- 1 Month Return
- -34.53 %
- 3 Month Return
- -31.35 %
- 1 Year Return
- -47.02 %
- 3 Year Return
- -46.34 %
- 5 Year Return
- -83.8 %
Ultragenyx Pharmaceutical Inc. Stock Fundamentals & Key Indicators
Check Ultragenyx Pharmaceutical Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.2B
EPS (TTM)
-5.7008
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-8.97
Industry PE ratio
5.1839
PEG Ratio
-0.24
EBITDA
-508.7M
Revenue (TTM)
630.6M
Profit Margin
-91.95%
Return On Equity TTM
-313.43%
Ultragenyx Pharmaceutical Inc. Stock Valuation
Track how Ultragenyx Pharmaceutical Inc. P/E has moved over time to understand its valuation trends.
Ultragenyx Pharmaceutical Inc. in the last 5 years
Lowest (-43.63x)
March 31, 2021
Today (-8.97x)
January 22, 2026
Industry (5.18x)
January 22, 2026
Highest (-3.89x)
December 31, 2022
Today’s Price to Earnings Ratio: -8.97x
Ultragenyx Pharmaceutical Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Ultragenyx Pharmaceutical Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $2.2B | -83.8% | -8.97 | -91.95% | |
| BUY | $47.0B | 112.01% | 1269.75 | 1.36% | |
| BUY | $113.3B | 94.09% | 31.15 | 31.35% | |
| NA | $37.0B | NA | 619.04 | 1.38% | |
| BUY | $77.8B | 39.34% | 17.58 | 32.13% |
Stock Returns calculator for Ultragenyx Pharmaceutical Inc. Stock including INR - Dollar returns
The Ultragenyx Pharmaceutical Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Ultragenyx Pharmaceutical Inc. investment value today
Current value as on today
₹60,640
Returns
Returns from Ultragenyx Pharmaceutical Inc. Stock
Dollar Returns*
₹5,913 (+5.91%)
Analyst Recommendation on Ultragenyx Pharmaceutical Inc. Stock
Based on 27 analysts
88.89%
Buy
11.11%
Hold
0.00%
Sell
Based on 27 analysts, 88.89% of analysts recommend a 'BUY' rating for Ultragenyx Pharmaceutical Inc.. Average target price of $63.9
Ultragenyx Pharmaceutical Inc. Share Price Target
Get share price movements and forecasts by analysts on Ultragenyx Pharmaceutical Inc..
What analysts predicted
63.22%UPSIDE
Target Price
$63.9
Current Price
$23.5
Analyzed by
27 Analysts
Target
$63.90
Ultragenyx Pharmaceutical Inc. target price $63.9, a slight upside of 63.22% compared to current price of $23.5. According to 27 analysts rating.
Ultragenyx Pharmaceutical Inc. Stock’s Investor Sentiment and Interest
Investment in Ultragenyx Pharmaceutical Inc. Shares on INDmoney has grown by 2850.00% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:2850.00% versus previous 30 day period
Search interest for Ultragenyx Pharmaceutical Inc. Stock has increased by 2189% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:2189% versus previous 30 day period
Ultragenyx Pharmaceutical Inc. Quarterly Profit & Loss
All numbers in Millions USD
Ultragenyx Pharmaceutical Inc. Annual Profit & Loss
All numbers in Millions USD
Ultragenyx Pharmaceutical Inc. Quarterly Cash Flow
All numbers in Millions USD
Ultragenyx Pharmaceutical Inc. Annual Cash Flow
All numbers in Millions USD
Ultragenyx Pharmaceutical Inc. News & Key Events
Today's Timeline - 29 December
Mon, 08:45 PM
-Ultragenyx shares hit 52-week low, down 43.96% after drug trials failed to meet primary endpoints.
Insights on Ultragenyx Pharmaceutical Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 28.2% return, outperforming this stock by 74.5%
- NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 53.7% return, outperforming this stock by 100.7%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, -114.95M → -180.41M (in $), with an average decrease of 57.0% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 166.49M → 159.93M (in $), with an average decrease of 3.9% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, RARE stock has moved down by -34.5%
About Ultragenyx Pharmaceutical Inc.
| Organisation | Ultragenyx Pharmaceutical Inc. |
| Headquarters | 60 Leveroni Court, Novato, CA, United States, 94949 |
| Industry | Health Technology |
| CEO | Dr. Emil D. Kakkis M.D., Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Ultragenyx Pharmaceutical Inc.
Name | Title |
|---|---|
Ms. Karah Herdman Parschauer J.D. | Chief Legal Officer & Executive VP of Corporate Affairs |
Mr. Ernie W. Meyer | Chief Human Resources Officer & Executive VP |
Mr. Vimal Srivastava | Senior Vice President of Business Development & Alliance Management |
Mr. Dennis Karl Huang | Chief Technical Operations Officer and Executive VP of Gene Therapy Operations |
Mr. Erik Harris M.B.A. | Executive VP & Chief Commercial Officer |
Mr. Howard Horn | Executive VP of Corporate Strategy & CFO |
Mr. John Richard Pinion II | Chief Quality Operations Officer & Executive VP of Translational Sciences |
Dr. Eric Crombez M.D. | Chief Medical Officer & Executive VP |
Mr. Theodore A. Huizenga | Senior VP, Corporate Controller & Principal Accounting Officer |
Dr. Emil D. Kakkis M.D., Ph.D. | Founder, President, CEO & Director |
FAQs
What is Ultragenyx Pharmaceutical Inc. share price today?
Ultragenyx Pharmaceutical Inc. share price today is $23.5 as on . Ultragenyx Pharmaceutical Inc. share today touched a day high of $23.87 and a low of $22.76.
What is the 52 week high and 52 week low for Ultragenyx Pharmaceutical Inc. share?
Ultragenyx Pharmaceutical Inc. share touched a 52 week high of $46.5 on and a 52 week low of $18.41 on . Ultragenyx Pharmaceutical Inc. stock price today i.e. is trending at $23.5,which is 49.46% down from its 52 week high and 27.65% up from its 52 week low.
What is Ultragenyx Pharmaceutical Inc.'s market capitalisation today?
Ultragenyx Pharmaceutical Inc. market capitalisation is $0.00T as on .
How to invest in Ultragenyx Pharmaceutical Inc. Stock (RARE) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Ultragenyx Pharmaceutical Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ultragenyx Pharmaceutical Inc. Shares that will get you 0.0638 shares as per Ultragenyx Pharmaceutical Inc. share price of $23.5 per share as on January 23, 2026 at 1:39 am IST.
What is the minimum amount required to buy Ultragenyx Pharmaceutical Inc. Stock (RARE) from India?
Indian investors can start investing in Ultragenyx Pharmaceutical Inc. (RARE) shares with as little as ₹91.567 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹915.67 in Ultragenyx Pharmaceutical Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Ultragenyx Pharmaceutical Inc. share’s latest price of $23.5 as on January 23, 2026 at 1:39 am IST, you will get 0.4255 shares of Ultragenyx Pharmaceutical Inc.. Learn more about
fractional shares .
What are the returns that Ultragenyx Pharmaceutical Inc. has given to Indian investors in the last 5 years?
Ultragenyx Pharmaceutical Inc. stock has given -83.8% share price returns and 24.55% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?